Summary : The drug received conditional marketing authorisation in the UK from the MHRA in November Beximco Pharma has announced that the…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Covid Drugs
-
-
AgrochemicalsCovid DrugsIndia
Biophore India receives Licences from MPP to market Molnupiravir
by adminby adminSynopsis : Natco Pharma Limited and Biophore India Pharmaceuticals have received the license from the Medicines Patent Pool (MPP), Switzerland, to manufacture and…
-
AgrochemicalsCovid DrugsGlobal Market
Poolbeg Pharma dives into nasally administered antivirals
by adminby adminSummary : If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at…
-
AgrochemicalsCovid Drugs
EMA Receives application for Conditional Marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
by adminby adminSynopsis: EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The…
-
AgrochemicalsCovid DrugsIndia
Indomethacin highly efficacious in treating Covid infection: Study
by adminby adminIndomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director…
-
Covid DrugsGlobal Market
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
by adminby adminSummary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…
-
AgrochemicalsCovid Drugs
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement
by adminby adminSummary : – Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – Together…
-
AstraZenecaCovid DrugsRegulatoryU.S FDA
FDA Approves AstraZeneca’s Evusheld becomes First Authorized COVID Antibody to Protect the Immunocompromised Before Exposure
by adminby adminSummary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Older Posts